Comparative Evaluation of Tacrolimus Versus Interferon Alpha-2b Eye Drops in the Treatment of Vernal Keratoconjunctivitis: A Randomized, Double-Masked Study Reply

被引：0
|
作者：
Pourazizi, Mohsen [1 ]
Ghafourian, Abdolhossein [2 ]
机构：
[1] Isfahan Univ Med Sci, Dept Ophthalmol, Esfahan, Iran
[2] Univ Tehran Med Sci, Farabi Eye Hosp, Eye Res Ctr, Dept Ophthalmol, Tehran, Iran
来源：
CORNEA | 2018年 / 37卷 / 01期
关键词：
D O I：
10.1097/ICO.0000000000001371
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：E1 / E2
页数：4
相关论文
共 50 条
  • [41] Multicenter, randomized, open-label study of the safety and efficacy of histamine dihydrochloride and interferon alpha-2b for the treatment of chronic hepatitis C: 48-week results
    Lurie, Y
    Hyle, S
    Gehlsen, K
    JOURNAL OF HEPATOLOGY, 2001, 34 : 165 - 166
  • [42] Retreatment with pegylated interferon alpha-2b and ribavirin in patients with chronic hepatitis C non responders to interferon monotherapy or interferon and ribavirin combination. A prospective randomized pilote study of two regimens: Induction versus regular dose pegylated interferon
    Bapin, C
    Fabbro-Peray, P
    Hachemane, S
    Larrey, D
    GASTROENTEROLOGY, 2004, 126 (04) : A721 - A721
  • [43] A Randomized, Double-Masked, Active-Controlled, Crossover Phase III Equivalence Study of Generic Dorzolamide 2% versus Innovator Trusopt® Eye Drop Solution in Subjects with Open-Angle Glaucoma or Ocular Hypertension
    Bell, Katharina
    Korb, Christina
    Butsch, Christina
    Giers, Bert Constantin
    Beck, Anna
    Strzalkowska, Alicja
    Ruckes, Christian
    Klingberg, Ulrike
    Pfeiffer, Norbert
    Lorenz, Katrin
    JOURNAL OF OPHTHALMOLOGY, 2022, 2022
  • [44] A phase II randomized study of adjuvant imatinib versus high-dose interferon alpha-2b for resected high-risk c-kit mutated melanoma.
    Si, Lu
    Wang, Xuan
    Kong, Yan
    Lian, Bin
    Chi, Zhi Hong
    Cui, Chuan Liang
    Sheng, Xi Nan
    Mao, Li Li
    Tang, Bi Xia
    Li, Si Ming
    Yan, Qiao Xie
    Guo, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [45] Treatment with pegylated-interferon alpha-2b (Peg-Interferon) plus ribavirin in relapsers to standard interferon plus ribavirin in chronic hepatitis C : Efficacy and safety results from a randomized multicentric french study.
    Portal, I
    Botta-Fridlund, D
    Bourliere, M
    Couzigou, P
    Barange, K
    Canva, V
    Larrey, D
    Rotily, M
    Halfon, P
    HEPATOLOGY, 2002, 36 (04) : 359A - 359A
  • [46] A prospective randomized study of CHOP versus CHOP plus alpha-2B interferon in patients with intermediate and high grade non-Hodgkin's lymphoma: The International Oncology Study Group NHL1 study
    Giles, FJ
    Shan, JQ
    Advani, SH
    Akan, H
    Aydogdu, I
    Aziz, Z
    Azim, HA
    Bapsy, PP
    Buyukkececi, F
    Chaimongkol, B
    Chen, PM
    Cheong, SK
    Ferhanoglu, B
    Hamza, R
    Khalid, HM
    Intragumtornchai, T
    Kim, SW
    Kim, SY
    Koc, H
    Kumar, L
    Kumar, R
    Lei, KI
    Lekhakula, A
    Muthalib, A
    Patel, M
    Poovalingam, VP
    Prayoonwiwat, W
    Rana, F
    Reksodiputro, AH
    Ruff, P
    Sagar, TG
    Schwarer, AP
    Song, HS
    Suh, CW
    Suharti, C
    Supindiman, I
    Tee, GY
    Thamprasit, T
    Villalon, AH
    Wickham, NR
    Wong, JE
    Yalcin, A
    Jootar, S
    LEUKEMIA & LYMPHOMA, 2000, 40 (1-2) : 95 - 103
  • [47] HIGH-DOSE VERSUS LOW-DOSE INTRAVESICAL INTERFERON-ALPHA-2B IN THE TREATMENT OF CARCINOMA INSITU - A RANDOMIZED, CONTROLLED-STUDY
    SAROSDY, M
    TORTI, FM
    FREIHA, F
    NARAYAN, P
    SCARDINO, PT
    MORALES, A
    WILLIAMS, RD
    FARRELL, CR
    CATALONA, WJ
    VOGELZANG, NJ
    CHODAK, G
    FLANAGAN, MJ
    PONTES, JE
    BAUER, HW
    SOLOWAY, MS
    LAMM, DL
    GLASHAN, RW
    CULLEN, D
    TENSEN, L
    SPIEGAL, RJ
    BONNEM, EM
    MARTINO, F
    SALFI, M
    NERI, RO
    ANTI-CANCER DRUGS, 1992, 3 : 13 - 17
  • [48] An open, multicenter, randomized trial comparing pegylated interferon alpha-2b (PEG-IFN) plus ribavirin (RBV) versus PEG-IFN for treatment of HIV/HCV co-infected patients.
    Cargnel, A
    Angeli, E
    Casella, A
    Gubertini, G
    Mainini, A
    Orlando, G
    Duca, P
    HEPATOLOGY, 2002, 36 (04) : 363A - 363A
  • [49] Therapy with interferon alpha-2b and ribavirin for hepatitis C patients: Comparison of a 6 months daily combined therapy versus 12 months every other day interferon plus daily ribavirin. Results of a controlled randomized study in 206 patients.
    Boucher, EJ
    Jacquelinet, S
    Danielou, H
    Turlin, B
    Colimon, R
    Guyader, D
    Brissot, P
    HEPATOLOGY, 2002, 36 (04) : 572A - 572A
  • [50] EVALUATION OF THE EFFECT OF TOPICAL INTERFERON α2b AS A COMPLEMENTARY TREATMENT OF MACULAR EDEMA OF PATIENTS WITH DIABETIC RETINOPATHY A Double-Blind Placebo-Controlled Randomized Clinical Trial Study
    Afarid, Mehrdad
    Meshksar, Aidin
    Salehi, Alireza
    Safarpour, Mohammad Mostafa
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2020, 40 (05): : 936 - 942
12345